Cresco Labs (CRLBF) EBIAT (2019 - 2025)
Historic EBIAT for Cresco Labs (CRLBF) over the last 7 years, with Q3 2025 value amounting to -$22.0 million.
- Cresco Labs' EBIAT fell 18552.12% to -$22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.7 million, marking a year-over-year increase of 963.97%. This contributed to the annual value of -$74.4 million for FY2024, which is 5861.15% up from last year.
- Latest data reveals that Cresco Labs reported EBIAT of -$22.0 million as of Q3 2025, which was down 18552.12% from -$13.9 million recorded in Q2 2025.
- Cresco Labs' 5-year EBIAT high stood at $23.7 million for Q1 2022, and its period low was -$263.5 million during Q3 2021.
- For the 5-year period, Cresco Labs' EBIAT averaged around -$37.8 million, with its median value being -$8.6 million (2021).
- As far as peak fluctuations go, Cresco Labs' EBIAT surged by 37529.07% in 2022, and later plummeted by 339168.98% in 2023.
- Cresco Labs' EBIAT (Quarter) stood at $11.9 million in 2021, then tumbled by 1616.44% to -$180.6 million in 2022, then surged by 102.7% to $4.9 million in 2023, then plummeted by 90.98% to $439000.0 in 2024, then crashed by 5104.1% to -$22.0 million in 2025.
- Its last three reported values are -$22.0 million in Q3 2025, -$13.9 million for Q2 2025, and -$15.2 million during Q1 2025.